Chester County News and Community Website
West Pharmaceutical Services, Inc. (NYSE: WST), headquartered in Exton, PA, is a leading manufacturer of packaging components and delivery systems for injectable drugs and healthcare products.
EXTON, PA — West Pharmaceutical Services Inc. (NYSE: WST) will present at two health care investor conferences in September, giving investors another opportunity to hear from the Exton-based injectable drug-delivery …
West Pharma Sets September Investor Conference Appearances Read More EXTON, PA — West Pharmaceutical Services Inc. (NYSE: WST) raised its full-year sales and earnings guidance after second-quarter revenue increased 13.8%, driven by demand for high-value components used in biologics, …
West Pharmaceutical Raises 2026 Outlook as Sales Accelerate Read More EXTON, PA — West Pharmaceutical Services Inc. (NYSE: WST) will pay a quarterly cash dividend of $0.22 per share on Aug. 5 to shareholders of record as of July 29, …
West Pharmaceutical Declares Quarterly Dividend for Shareholders Read More EXTON, PA — West Pharmaceutical Services Inc. (NYSE: WST) will report second-quarter 2026 financial results before markets open on July 23, giving investors an update on demand for drug delivery …
West Pharmaceutical Sets July 23 Earnings Release, Outlook Call Read More EXTON, PA — West Pharmaceutical Services Inc. (NYSE: WST) completed the sale and transfer of manufacturing and supply rights for its SmartDose 3.5mL On-Body Delivery System on July 1, narrowing …
West Pharma Completes SmartDose 3.5mL Rights Sale Read More EXTON, PA — West Pharmaceutical Services (NYSE: WST) has appointed former Thermo Fisher Scientific executive Michel Lagarde as president and chief executive officer, positioning the drug-delivery manufacturer for its next …
West Pharmaceutical Names Thermo Fisher Executive as CEO Read More EXTON, PA — West Pharmaceutical Services, Inc. (NYSE: WST) will present at two investor conferences in May and June, with webcasts available through its investor relations website.
West Pharmaceutical to Present at May, June Investor Conferences Read More EXTON, PA — West Pharmaceutical Services Inc. (NYSE: WST) reported first-quarter 2026 net sales of $844.9 million and diluted earnings per share of $1.92, reflecting increases of 21.0% and 56.1%, …
West Pharmaceutical Reports Higher First-Quarter Revenue, Earnings Read More EXTON, PA — West Pharmaceutical Services, Inc. (NYSE: WST) said it will release first-quarter 2026 financial results before markets open Thursday, April 23, and will host a conference call at …
West Pharmaceutical Services to Report Q1 Results April 23 Read More EXTON, PA — West Pharmaceutical Services Inc. (NYSE: WST) has opened a 165,000-square-foot expansion at its Damastown site in Dublin to increase contract manufacturing capacity for high-volume injectable therapies, including …
West Pharmaceutical Opens Dublin Expansion to Boost Capacity Read More